319 related articles for article (PubMed ID: 22522680)
1. Precise manipulation of the Clostridium difficile chromosome reveals a lack of association between the tcdC genotype and toxin production.
Cartman ST; Kelly ML; Heeg D; Heap JT; Minton NP
Appl Environ Microbiol; 2012 Jul; 78(13):4683-90. PubMed ID: 22522680
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile.
Goldenberg SD; French GL
J Infect; 2011 May; 62(5):355-62. PubMed ID: 21396957
[TBL] [Abstract][Full Text] [Related]
3. Rapid detection of the Clostridium difficile ribotype 027 tcdC gene frame shift mutation at position 117 by real-time PCR and melt curve analysis.
Wolff D; Brüning T; Gerritzen A
Eur J Clin Microbiol Infect Dis; 2009 Aug; 28(8):959-62. PubMed ID: 19333630
[TBL] [Abstract][Full Text] [Related]
4. Mathematical modelling reveals properties of TcdC required for it to be a negative regulator of toxin production in Clostridium difficile.
Jabbari S; Cartman ST; King JR
J Math Biol; 2015 Mar; 70(4):773-804. PubMed ID: 24687436
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.
Spigaglia P; Mastrantonio P
J Clin Microbiol; 2002 Sep; 40(9):3470-5. PubMed ID: 12202595
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of pathogenicity locus (PaLoc) and tcdC genetic diversity among tcdA
Kodori M; Ghalavand Z; Yadegar A; Eslami G; Azimirad M; Krutova M; Abadi A; Zali MR
Anaerobe; 2020 Dec; 66():102294. PubMed ID: 33181348
[TBL] [Abstract][Full Text] [Related]
7. Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.
Murray R; Boyd D; Levett PN; Mulvey MR; Alfa MJ
BMC Infect Dis; 2009 Jun; 9():103. PubMed ID: 19558711
[TBL] [Abstract][Full Text] [Related]
8. TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm.
Bakker D; Smits WK; Kuijper EJ; Corver J
PLoS One; 2012; 7(8):e43247. PubMed ID: 22912837
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.
Sirard S; Valiquette L; Fortier LC
J Clin Microbiol; 2011 Dec; 49(12):4040-6. PubMed ID: 21956985
[TBL] [Abstract][Full Text] [Related]
10. The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.
Oliveira Paiva AM; de Jong L; Friggen AH; Smits WK; Corver J
J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32868401
[No Abstract] [Full Text] [Related]
11. The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile.
Carter GP; Douce GR; Govind R; Howarth PM; Mackin KE; Spencer J; Buckley AM; Antunes A; Kotsanas D; Jenkin GA; Dupuy B; Rood JI; Lyras D
PLoS Pathog; 2011 Oct; 7(10):e1002317. PubMed ID: 22022270
[TBL] [Abstract][Full Text] [Related]
12. Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR.
Bouvet PJ; Popoff MR
J Clin Microbiol; 2008 Nov; 46(11):3703-13. PubMed ID: 18832125
[TBL] [Abstract][Full Text] [Related]
13. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
[TBL] [Abstract][Full Text] [Related]
14. A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1.
Hoegh AM; Nielsen JB; Lester A; Friis-Møller A; Schønning K
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1073-9. PubMed ID: 21938539
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.
Matamouros S; England P; Dupuy B
Mol Microbiol; 2007 Jun; 64(5):1274-88. PubMed ID: 17542920
[TBL] [Abstract][Full Text] [Related]
16. Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC.
Persson S; Jensen JN; Olsen KE
J Clin Microbiol; 2011 Dec; 49(12):4299-300. PubMed ID: 21976756
[TBL] [Abstract][Full Text] [Related]
17. tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile.
Curry SR; Marsh JW; Muto CA; O'Leary MM; Pasculle AW; Harrison LH
J Clin Microbiol; 2007 Jan; 45(1):215-21. PubMed ID: 17035492
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms of the tcdC gene and presence of the binary toxin gene predict recurrent episodes of Clostridium difficile infection.
Stewart DB; Berg AS; Hegarty JP
Ann Surg; 2014 Aug; 260(2):299-304. PubMed ID: 24374512
[TBL] [Abstract][Full Text] [Related]
19. Evidence that Clostridium difficile TcdC is a membrane-associated protein.
Govind R; Vediyappan G; Rolfe RD; Fralick JA
J Bacteriol; 2006 May; 188(10):3716-20. PubMed ID: 16672625
[TBL] [Abstract][Full Text] [Related]
20. Spo0A differentially regulates toxin production in evolutionarily diverse strains of Clostridium difficile.
Mackin KE; Carter GP; Howarth P; Rood JI; Lyras D
PLoS One; 2013; 8(11):e79666. PubMed ID: 24236153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
